Russell Investments Group’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,400
| Closed | -$8.58K | – | 3787 |
|
|
2024
Q3 | $8.58K | Hold |
6,400
| – | – | ﹤0.01% | 3120 |
|
|
2024
Q2 | $8.32K | Hold |
6,400
| – | – | ﹤0.01% | 3114 |
|
|
2024
Q1 | $11K | Hold |
6,400
| – | – | ﹤0.01% | 2840 |
|
|
2023
Q4 | $9.41K | Hold |
6,400
| – | – | ﹤0.01% | 2832 |
|
|
2023
Q3 | $7.74K | Hold |
6,400
| – | – | ﹤0.01% | 3069 |
|
|
2023
Q2 | $9.28K | Hold |
6,400
| – | – | ﹤0.01% | 2977 |
|
|
2023
Q1 | $9.28K | Hold |
6,400
| – | – | ﹤0.01% | 2896 |
|
|
2022
Q4 | $11.1K | Hold |
6,400
| – | – | ﹤0.01% | 2839 |
|
|
2022
Q3 | $12K | Hold |
6,400
| – | – | ﹤0.01% | 2851 |
|
|
2022
Q2 | $4K | Sell |
6,400
-850
| -12% | -$531 | ﹤0.01% | 2858 |
|
|
2022
Q1 | $63K | Hold |
7,250
| – | – | ﹤0.01% | 2614 |
|
|
2021
Q4 | $116K | Sell |
7,250
-897
| -11% | -$14.4K | ﹤0.01% | 2820 |
|
|
2021
Q3 | $149K | Sell |
8,147
-9,222
| -53% | -$169K | ﹤0.01% | 2822 |
|
|
2021
Q2 | $241K | Sell |
17,369
-31,798
| -65% | -$441K | ﹤0.01% | 2850 |
|
|
2021
Q1 | $723K | Sell |
49,167
-2,600
| -5% | -$38.2K | ﹤0.01% | 2370 |
|
|
2020
Q4 | $1.01M | Sell |
51,767
-64,761
| -56% | -$1.26M | ﹤0.01% | 2116 |
|
|
2020
Q3 | $1.29M | Buy |
116,528
+23,200
| +25% | +$257K | ﹤0.01% | 1938 |
|
|
2020
Q2 | $1.26M | Buy |
93,328
+82,587
| +769% | +$1.11M | ﹤0.01% | 1915 |
|
|
2020
Q1 | $86K | Buy |
10,741
+4,873
| +83% | +$39K | ﹤0.01% | 2771 |
|
|
2019
Q4 | $55K | Buy |
+5,868
| New | +$55K | ﹤0.01% | 2984 |
|
|
2018
Q4 | – | Sell |
-1,300
| Closed | -$14K | – | 3027 |
|
|
2018
Q3 | $14K | Sell |
1,300
-700
| -35% | -$7.54K | ﹤0.01% | 2917 |
|
|
2018
Q2 | $29K | Buy |
+2,000
| New | +$29K | ﹤0.01% | 2861 |
|